She and other groups have participated in an interlaboratory test of standardized reference materials for detecting cancer somatic mutations, with results that will be published in the coming months.
In this SeraCare interview, Dr. Ferreira-Gonzalez identifies seven benefits of using expert-designed multiplexed standard reference materials, such as the Seraseq Tumor Mutation DNA Mix v2 (AF10) HC, to gain confidence in detecting a variety of genetic changes. Generating data at multiple laboratories and across multiple platforms with the same standard material shows not only how robust the technology is, but also speaks to the quality of the reference material.
From initial validation through full-scale clinical practice, for proficiency testing and laboratory training, Dr. Ferreira-Gonzalez explains how valuable these materials are for her laboratory. You can access this interview here.